Hostname: page-component-78c5997874-ndw9j Total loading time: 0 Render date: 2024-11-04T21:31:04.472Z Has data issue: false hasContentIssue false
  • English
  • Français

Chasing the rate: An interrupted time series analysis of interventions targeting reported hospital onset Clostridioides difficile, 2013–2018

Published online by Cambridge University Press:  04 June 2020

Michelle E. Doll Open the ORCID record for Michelle E. Doll [Opens in a new window] ,
Jinlei Zhao ,
Le Kang ,
Barry Rittmann ,
Michael Alvarez ,
Michele Fleming ,
Kaila Cooper ,
Michael P. Stevens  and
Gonzalo Bearman
Michelle E. Doll*
Affiliation:
Virginia Commonwealth School of Medicine, Richmond, Virginia Virginia Commonwealth University Health System, Richmond, Virginia
Jinlei Zhao
Affiliation:
Virginia Commonwealth School of Medicine, Richmond, Virginia
Le Kang
Affiliation:
Virginia Commonwealth School of Medicine, Richmond, Virginia
Barry Rittmann
Affiliation:
Virginia Commonwealth University Health System, Richmond, Virginia
Michael Alvarez
Affiliation:
Virginia Commonwealth University Health System, Richmond, Virginia
Michele Fleming
Affiliation:
Virginia Commonwealth University Health System, Richmond, Virginia
Kaila Cooper
Affiliation:
Virginia Commonwealth University Health System, Richmond, Virginia
Michael P. Stevens
Affiliation:
Virginia Commonwealth School of Medicine, Richmond, Virginia Virginia Commonwealth University Health System, Richmond, Virginia
Gonzalo Bearman
Affiliation:
Virginia Commonwealth School of Medicine, Richmond, Virginia Virginia Commonwealth University Health System, Richmond, Virginia
*
Author for correspondence: Michelle Doll, E-mail: [email protected]
Get access Rights & Permissions [Opens in a new window]

Abstract

Objective:

To assess the impact of major interventions targeting infection control and diagnostic stewardship in efforts to decrease Clostridioides difficile hospital onset rates over a 6-year period.

Design:

Interrupted time series.

Setting:

The study was conducted in an 865-bed academic medical center.

Methods:

Monthly hospital-onset C. difficile infection (HO-CDI) rates from January 2013 through January 2019 were analyzed around 5 major interventions: (1) a 2-step cleaning process in which an initial quaternary ammonium product was followed with 10% bleach for daily and terminal cleaning of rooms of patients who have tested positive for C. difficile (February 2014), (2) UV-C device for all terminal cleaning of rooms of C. difficile patients (August 2015), (3) “contact plus” isolation precautions (June 2016), (4) sporicidal peroxyacetic acid and hydrogen peroxide cleaning in all patient areas (June 2017), (5) electronic medical record (EMR) decision support tool to facilitate appropriate C. difficile test ordering (March 2018).

Results:

Environmental cleaning interventions and enhanced “contact plus” isolation did not impact HO-CDI rates. Diagnostic stewardship via EMR decision support decreased the HO-CDI rate by 6.7 per 10,000 patient days (P = .0079). When adjusting rates for test volume, the EMR decision support significance was reduced to a difference of 5.1 case reductions per 10,000 patient days (P = .0470).

Conclusion:

Multiple aggressively implemented infection control interventions targeting CDI demonstrated a disappointing impact on endemic CDI rates over 6 years. This study adds to existing data that outside of an outbreak situation, traditional infection control guidance for CDI prevention has little impact on endemic rates.

Type
Original Article
Information
Infection Control & Hospital Epidemiology , Volume 41 , Issue 10 , October 2020 , pp. 1142 - 1147
Check for updates
Copyright
© 2020 by The Society for Healthcare Epidemiology of America. All rights reserved.

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

References

Magill, SS, Edwards, JR, Bamberg, W, et al.Multistate point-prevalence survey of health care–associated infections for the Emerging Infections Program Healthcare-Associated Infections and Antimicrobial Use Prevalence Survey Team, Centers for Disease Control and Prevention. N Engl J Med 2014;370:1198–1208.10.1056/NEJMoa1306801CrossRefGoogle Scholar
Morgan, DJ, Leekha, S, Croft, L, et al.The importance of colonization with Clostridium difficile on infection and transmission. Curr Infect Dis Rep 2015;17:499.10.1007/s11908-015-0499-0CrossRefGoogle ScholarPubMed
Polage, CR, Gyorke, CE, Kennedy, MA, et al.Overdiagnosis of Clostridium difficile infection in the molecular test era. JAMA Intern Med 2015;175:1792–1801.10.1001/jamainternmed.2015.4114CrossRefGoogle ScholarPubMed
Yen, C, Holtom, P, Butler-Wu, SM, Wald-Dickler, N, Shulman, I, Spellberg, B. Reducing Clostridium difficile colitis rates via cost-saving diagnostic stewardship. Infect Control Hosp Epidemiol 2018;39:734–736.CrossRefGoogle ScholarPubMed
Madden, GR, German Mesner, I, Cox, HL, et al.Reduced Clostridium difficile tests and laboratory-identified events with a computerized clinical decision support tool and financial incentive. Infect Control Hosp Epidemiol 2018;39:737–740.CrossRefGoogle ScholarPubMed
Culbreath, K, Ager, E, Nemeyer, RJ, Kerr, A, Gilligan, PH.Evolution of testing algorithms at a university hospital for detection of Clostridium difficile infections. J Clin Microbiol 2012;50:3073–3076.CrossRefGoogle Scholar
Abbett, SK, Yokoe, DS, Lipsitz, SR, et al.Proposed checklist of hospital interventions to decrease the incidence of healthcare-associated Clostridium difficile infection. Infect Control Hosp Epidemiol 2009;30:1062–1069.10.1086/644757CrossRefGoogle ScholarPubMed
Weiss, K, Boisvert, A, Chagnon, M, et al.Multipronged intervention strategy to control an outbreak of Clostridium difficile infection (CDI) and its impact on the rates of CDI from 2002 to 2007. Infect Control Hosp Epidemiol 2009;30:156–162.CrossRefGoogle ScholarPubMed
McDonald, LC, Gerding, DN, Johnson, S, et al.Clinical practice guidelines for Clostridium difficile infection in adults and children: 2017 Update by the Infectious Diseases Society of America (IDSA) and Society for Healthcare Epidemiology of America (SHEA). Clin Infect Dis 2018;66(7):e1–e48.CrossRefGoogle Scholar
Dubberke, ER, Carling, P, Carrico, R, et al.Strategies to prevent Clostridium difficile infections in acute-care hospitals: 2014 update. Infect Control Hosp Epidemiol 2014;35:628–645.10.1086/676023CrossRefGoogle ScholarPubMed
Perencevich, EN, Thom, KA. Preventing Clostridium difficile–associated disease: is it time to pay the piper? Infect Control Hosp Epidemiol 2008;29:829–831.CrossRefGoogle ScholarPubMed
Daneman, N, Guttmann, A, Wang, X, Ma, X, Gibson, D, Stukel, TA.The association of hospital prevention processes and patient risk factors with the risk of Clostridium difficile infection: a population-based cohort study. BMJ Qual Saf 2015;24:435–443.CrossRefGoogle ScholarPubMed
Eyre, DW, Cule, ML, Wilson, DJ, et al.Diverse sources of C. difficile infection identified on whole-genome sequencing. N Engl J Med 2013;369:1195–1205.10.1056/NEJMoa1216064CrossRefGoogle ScholarPubMed
Multidrug-resistant organism & Clostridioides difficile infection (MDRO/CDI) module. Centers for Disease Control National Healthcare Safety Network website. https//www.cdc.gov/nhsn/pdfs/pscmanual/12pscmdro_cdadcurrent.pdf. 2019. Updated January, 2019. Accessed August 24, 2019.Google Scholar
Doll, M. Appropriateness of molecular testing for Clostridium difficile: an evaluation of provider ordering. In: Program and abstracts of the International Congress on Infectious Diseases; March 1, 2018; Buenos Aires, Argentina.Google Scholar
Procedure-associated module: surgical site infection. Centers for Disease Control National Healthcare Safety Network website. https://www.cdc.gov/nhsn/pdfs/pscmanual/9pscssicurrent.pdf. Updated January 2019. Accessed July 7, 2019.Google Scholar
Fleming, MS, Hess, O, Albert, HL, et al.Test stewardship, frequency and fidelity: impact on reported hospital-onset Clostridioides difficile. Infect Control Hosp Epidemiol 2019;40:710–712.10.1017/ice.2019.63CrossRefGoogle ScholarPubMed
Dingle, KE, Didelot, X, Quan, TP, et al.Effects of control interventions on Clostridium difficile infection in England: an observational study. Lancet Infect Dis 2017;17:411–421.10.1016/S1473-3099(16)30514-XCrossRefGoogle ScholarPubMed
Kazakova, S V, Baggs, J, McDonald, LC, et al.Association between antibiotic use and hospital-onset Clostridioides difficile infection in US acute care hospitals, 2006–2012: an ecologic analysis Clin Infect Dis 2020;70:11–18.CrossRefGoogle ScholarPubMed
Mejia-Chew, C, Dubberke, ER.Clostridium difficile control measures: current and future methods for prevention. Expert Rev Anti Infect Ther 2018;16:121–131.CrossRefGoogle ScholarPubMed
Supplementary material: File

Doll et al. supplementary material

Appendix 1

Download Doll et al. supplementary material(File)
File 15.3 KB